CompoAtlas

Rhodiola BIO : complément alimentaire en gélule à base d'extrait sec de rhodiola

Food supplement declared in France, declaration No 2019-5-367

Rhodiola BIO : complément alimentaire en gélule à base d'extrait sec de rhodiola (L'Herbôthicaire) is a food supplement declared in France. Status: withdrawn from the market on 9 October 2024. None of the rules we check flags an issue with its declared composition.

Brand
L'Herbôthicaire
Food business operator placing the product on the market
ACBNature
Status
Withdrawn from the market on 9 October 2024
Form
Capsule
Daily dose
95 mg
Directions for use
Prendre une gélule par jour avec un grand verre d'eau
Intended populations
Adolescents aged 11 to 17, People over 60, Men, Women
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Sleep

Declaration 213181, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Acacia senegal (L.) Willd.GommePoudre (de plantes séchées ou broyées)160 mg
Sedum roseum (L.) Scop.RacinePoudre (de plantes séchées ou broyées)95 mg

Other ingredients

maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes et allaitantes. Ce complément alimentaire n'est pas un médicament. En cas de doute, toujours se référer à l'avis d'un professionnel de santé. Ne pas dépasser les doses conseillées. A consommer dans le cadre d'un mode de vie sain. Les compléments alimentaires ne doivent pas être utilisés comme substitut d'un régime alimentaire varié et équilibré. Tenir hors de la portée des enfants. Conserver dans son emballage à l'abri de la lumière, de la chaleur et de l'humidité.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sedum roseum (L.) Scop.
    Read the warning, when it applies and the studies cited

    RHODIOLA - RHODIOLA ROSEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    Sources cited by Health Canada (1)
    • EMA 2024: 20 March 2024 EMA/HMPC/24177/2023 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Rhodiola rosea L., rhizoma et radix Final - Revision 1. Amsterdam (NL): European Medicines Agency, Science Medicines Health. [Accessed 2025 January 21]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-rhodiola-rosea-l-rhizoma-et-radix-revision-1_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, hormone replacement therapy (HRT) or birth control medication (HC 2018; Iovieno et al. 2011; Olsson et al. 2009; Brown et al. 2002).

    Sources cited by Health Canada (4)
    • Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
    • HC 2018: Health Canada. Canada Vigilance Adverse Reaction Online Database. Ottawa (ON): Marketed Health Products Directorate, Health Canada. [Accessed 2025 January 21]. Available from: https://cvp-pcv.hc-sc.gc.ca/arq-rei/index-eng.jsp
    • Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
    • SC 2018: Santé Canada. Base de données en ligne des effets indésirables de Canada Vigilance. Ottawa (ON): Direction des produits de santé commercialisés, Santé Canada. [Consulté le 21 janvier 2025]. Disponible à : https://cvp-pcv.hc-sc.gc.ca/arq-rei/switchlocale.do?lang=fr&url=t.search.recherche

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have bipolar disorder or bipolar spectrum disorder (Iovieno et al. 2011; Winston and Maimes 2007; Brown et al. 2002).

    Sources cited by Health Canada (3)
    • Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
    • Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
    • Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester (VT): Healing Arts Press, 2007.

    Known adverse reactions

    Stop use if you experience irritability or insomnia (Pizzorno and Murray 2006; Kelly 2001).

    Sources cited by Health Canada (2)
    • Kelly GS. Rhodiola rosea: A Possible Plant Adaptogen. Alternative Medicine Review 2001;6(3): 293-302. PubMed Review article
    • Pizzorno JE, Murray MT, editors. Textbook of Natural Medicine. 3rd edition, volume 1. St. Louis (MI): Churchill Livingstone Elsevier; 2006.

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : L'Herbôthicaire

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line